Match Document Document Title
US20150094278 METHODS OF DIAGNOSING, GRADING, MONITORING, AND TREATING HEPATIC ENCEPHALOPATHY  
The present disclosure provides methods, systems, and instruments for the determination by a physician or medical professional whether a subject is experiencing or has recently experienced an...
US20120202753 INHIBITING INFLAMMATION WITH MILK OLIGOSACCHARIDES  
A method of inhibiting inflammation in a subject comprising the administration of milk oligosaccharides or glycoconjugates containing milk oligosaccharides is disclosed.
US20120244222 OSMOTIC MEDIATED RELEASE SYNTHETIC NANOCARRIERS  
This invention relates, at least in part, to osmotic mediated release barrier-free synthetic nanocarriers and methods of production and use.
US20110311442 DIRECT CELLULAR ENERGY DELIVERY SYSTEM  
A lipid vesicle comprising a phospholipid which is a stable vesicle former and at least one unstable vesicle forming member, wherein the unstable vesicle forming member is selected from the group...
US20140213530 METHODS FOR TREATMENT OF CANCER BY TARGETING SIRT5  
This disclosure demonstrates that inhibition of Sirt5 can suppress malignant transformation of cells. Therefore, methods of treating cancer based on inhibition of Sirt5 are disclosed.
US20120114723 ONE STEP FIRE ANT CONTROL  
The present invention relates to a method for controlling fire ants with a single step application of a combination of a bait and a controlled release treatment composition, and to the novel...
US20110098238 ELUCIDATING LIGAND-BINDING INFORMATION BASED ON PROTEIN TEMPLATES  
A method, computer-readable medium, and system for identifying compounds from chemical libraries that can be used for the therapeutic treatment of a disease or used as lead compounds in a drug...
US20150157612 METHODS OF TREATING HEPATIC ENCEPHALOPATHY  
The application describes treatment of hepatic encephalopathy using gastrointestinal specific antibiotics. One example of a gastrointestinal specific antibiotic is rifaximin.
US20130171090 METHODS OF TREATING HEPATIC ENCEPHALOPATHY  
The application describes treatment of hepatic encephalopathy using gastrointestinal specific antibiotics. One example of a gastrointestinal specific antibiotic is rifaximin.
US20110243879 METHODS OF TREATING HEPATIC ENCEPHALOPATHY  
The application describes treatment of hepatic encephalopathy using gastrointestinal specific antibiotics. One example of a gastrointestinal specific antibiotic is rifaximin.
US20150141367 MODULATION OF GROWTH OF BIFIDOBACTERIA USING A COMBINATION OF OLIGOSACCHARIDES FOUND IN HUMAN MILK  
A prebiotic formulation for oral administration to a human comprising 2′-fucosyllactose, 3′-sialyllactose and 6′-sialyllactose, and a method for modulating or stimulating the growth of...
US20120208782 Modulation of Growth of Bifidobacteria Using a Combination of Oligosaccharides Found in Human Milk  
A prebiotic formulation for oral administration to a human comprising 2′-fucosyllactose, 3′-sialyllactose and 6′-sialyllactose, and a method for modulating or stimulating the growth of...
US20140336145 COMPOSITIONS AND METHODS FOR TREATING OCULOPHARYNGEAL MUSCULAR DYSTROPHY  
The present invention provides intravenous compositions of trehalose for the treatment of signs and symptoms of oculopharyngeal muscular dystrophy (OPMD).
US20150133398 Prebiotic Formulations and Methods of Use  
The invention provides methods and compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and...
US20140348774 METHOD FOR TREATING WOUNDS AND TISSUE REPAIR  
The present inventions relate to a number of fields including wound healing, a waterless antibacterial disinfectant, a surgical scrub, insect repellant, and methods of treating traumatic injuries,...
US20140303115 LACTULOSE FOR BOWEL EVACUATION  
A method of treating an adult patient in need of bowel evacuation via the administration of one or more doses of a bowel evacuant consisting of a total of from about 180 g to about 220 g of...
US20120277181 LACTULOSE FOR BOWEL EVACUATION  
A method of treating an adult patient in need of bowel evacuation via the administration of one or more doses of a bowel evacuant consisting of a total of from about 180 g to about 220 g of...
US20130190266 FRUCTOSYLATED PUERARIN, AND PREPARATION METHOD AND USE THEREOF  
Fructosylated puerarin being converted from puerarin by a bioconversion method conducted in an aqueous phase or nonaqueous phase system, including monofructosyl-(2,6)-puerarin,...
US20140200194 USE OF URARIA IN PROMOTING OSTEOGENESIS OR PROVIDING NEUROPROTECTION  
The invention provides a method for promoting osteogenesis, increasing bone mass or enhancing the rate of bone growth, which comprises administering to a subject an effective amount of Uraria, a...
US20140328904 GLA MONOTHERAPY FOR USE IN CANCER TREATMENT  
The present disclosure relates generally to compositions and methods for treating cancer with a glucopyranosyl lipid A (GLA) in the absence of antigen.
US20140314834 GLA MONOTHERAPY FOR USE IN CANCER TREATMENT  
The present disclosure relates generally to compositions and methods for treating cancer with a glucopyranosyl lipid A (GLA) in the absence of antigen.
US20120064165 TREATMENT OF TISSUE ADHESION  
Dry powder compositions are useful in the treatment or prevention of tissue adhesions during or after surgery or during wound therapy. The dry powder compositions may contain trehalose. The dry...
US20130345166 METHODS OF TREATING HEPATIC ENCEPHALOPATHY  
The application describes treatment of hepatic encephalopathy using gastrointestinal specific antibiotics. One example of a gastrointestinal specific antibiotic is rifaximin. The instant...
US20130123209 METHODS OF TREATING HEPATIC ENCEPHALOPATHY  
The application describes treatment of hepatic encephalopathy using gastrointestinal specific antibiotics. One example of a gastrointestinal specific antibiotic is rifaximin. The instant...
US20110071103 METHODS OF TREATING HEPATIC ENCEPHALOPATHY  
The application describes treatment of hepatic encephalopathy using gastrointestinal specific antibiotics. One example of a gastrointestinal specific antibiotic is rifaximin. The instant...
US20110105426 COMPOSITIONS AND METHODS FOR TREATING CORNEAL INFLAMMATION  
A method of treating corneal inflammation in a subject includes administering to the subject a therapeutically effective amount of a TLR4 antagonist.
US20140135281 METHODS FOR CONTROLLING VARROA MITES  
The present invention relates to methods and compositions comprising cyromazine for the control of bee mites and for the reduction of bee mite infestations, such as the control and reduction of...
US20110201569 Methods For Treating Myocardial Disorders  
Provided are methods for treating myocardial disorders comprising administering to a subject an effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof.
US20110280970 ABSORBABLE PUTTY-LIKE IMPLANTS AND METHODS FOR THEIR USE FOR MECHANICAL HEMOSTASIS OF BONE AND FOR THE TREATMENT OF OSSEOUS DEFECTS  
The present invention relates to mechanically hemostatic body-absorbable compositions having a putty-like consistency comprising a finely powdered, carboxylic acid salt, a liquid block copolymer...
US20140162974 METHODS FOR MODULATION OF PHOSPHORUS AND FGF23  
Compositions and methods for decreasing phosphorus, decreasing cFGF23, or increasing iFGF23 in a subject. Such compositions and methods can be useful for treatment of conditions, disorders, or...
US20110274775 EXTRACTS OF SOUTHERNWOOD AND TOPICAL USES THEREOF  
The present invention relates to a method of treating visibly dry skin. The method includes topically applying a composition comprising a Southernwood extract to said skin.
US20110117031 METHOD FOR TREATING HYPERSENSITIVE TEETH  
A method for imparting a teeth-desensitising effect to a food, cosmetic or pharmaceutical which comprises combining said food, cosmetic or pharmaceutical with a teeth-desensitising effective...
US20140170106 METHODS AND COMPOSITIONS SUITABLE FOR IMPROVED REATTACHMENT OF DETACHED CARTILAGE TO SUBCHONDRAL BONE  
The methods and compositions disclosed herein are effective in the promoting the reattachment of delaminated cartilage to bone. The methods (and related compositions) comprise the removal of the...
US20110223248 METHODS AND COMPOSITIONS FOR TREATING LACTOSE INTOLERANCE  
The invention provides methods and compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and...
US20130336899 ANTIMICROBIAL FORMULATIONS THAT AID IN WOUND HEALING  
The invention discloses compositions and formulations for the treatment of clean or infected wounds, some of the inventive formulations can be used to reduce or eliminate microbial contamination...
US20150098987 TRANS-RESVERATROL POLYSACCHARIDE, METHOD OF PRODUCING THEREOF, AND COMPOSITION COMPRISING THEREOF  
An object of the present invention is to provide a trans-resveratrol derivative that resists isomerization to the cis-form. This object can be achieved by a method for producing a...
US20140234407 Method for Increasing Lactose Tolerance in Mammals Exhibiting Lactose Intolerance  
The method for increasing lactose tolerance in subjects exhibiting lactose intolerance symptoms implements a protocol where the subjects ingest a gradually increasing amount of lactose containing...
US20130034601 METHOD FOR INCREASING LACTOSE TOLERANCE IN MAMMALS EXHIBITING LACTOSE INTOLERANCE  
The method for increasing lactose tolerance in subjects exhibiting lactose intolerance symptoms implements a protocol where the subjects ingest a gradually increasing amount of lactose containing...
US20110086093 METHOD FOR INCREASING LACTOSE TOLERANCE IN MAMMALS EXHIBITING LACTOSE INTOLERANCE  
The method for increasing lactose tolerance in subjects exhibiting lactose intolerance symptoms implements a protocol where the subjects ingest a gradually increasing amount of lactose containing...
US20140065062 Halogenated Di and Trisaccharides, Pharmaceutical Formulations, Diagnostic Kits and Methods of Treatment  
The present invention relates to a novel family of alkylated halogenated di- and trisaccharides which exhibit pharmaceutical efficacy in the areas of permeation enhancers, anti-microbial effects,...
US20140017301 DRUG-FREE COMPOSITIONS AND METHODS FOR DIMINISHING PERIPHERAL INFLAMMATION AND PAIN  
The present invention provides drug-free adaptable aggregate compositions, typically having a form of bilayer vesicles suspended in a polar, optionally thickened, fluid comprising different...
US20120157406 METHOD OF PREVENTING DIARRHOEA  
The present invention provides a method for the prevention of the incidence of and/or a reduction in the duration of acute diarrhoea, particularly in travellers, said method comprising orally...
US20110028400 SULFATED UNSATURATED DISACCHARIDIC CHONDROITIN SULFATE IN CONNECTIVE TISSUE PROTECTION AND REPAIR  
The present invention generally relates to the protection and repair of connective tissues. In particular, the present invention relates to the use of chondroitin sulfates and its derivatives in...
US20140155346 COSMETIC AND/OR DERMATOLOGICAL USE OF OLIGOSACCHARIDE COMPOUNDS FOR PREVENTING AND TREATING STRETCH MARKS  
The present invention relates to a topical composition, in particular a cosmetic and/or dermatological composition, to be used for preventing and/or treating stretch marks, including, in a...
US20150202224 METHOD OF TREATING IRON DEFICIENCY ANEMIA  
Methods for predicting responsiveness of a subject to iron therapy and treatment methods related thereto. Such methods can be useful with respect to conditions, disorders, or diseases associated...
US20130078317 ZINC-CONTAINING COMPOSITIONS FOR THE TREATMENT OF DISEASES, ILLNESSES AND SYNDROMES ASSOCIATED WITH EXPOSURE TO PORE FORMING TOXINS  
Embodiments of the invention relate to compositions and methods of using the same to treat conditions caused by exposure to a pore-forming toxin.
US20150232581 Methods for Purifying Polysaccharides and Pharmaceutical Compositions and Medical Devices Containing the Same  
Methods for removing endotoxin from naturally occurring materials, such as polysaccharides (e.g., agarose and/or carrageenan) are described herein. Polysaccharides that are substantially free of...
US20110082102 USE OF PREBIOTIC GALACTO-OLIGOSACCHARIDES IN THE TREATMENT OF INTESTINAL INFLAMMATION  
The present invention relates to the use of an oligosaccharide, in particular a non-digestible oligosaccharide, composition in the prevention or treatment of inflammation, in particular intestinal...
US20110104279 HEALING POWDER AND METHOD OF USE THEREOF  
A method for treating wounds, comprising providing a dry powder mixture, which when partially hydrated, forms a gel having an osmotic pressure sufficient to achieve and maintain antiseptic...
US20130171093 HEALING POWDER AND METHOD OF USE THEREOF  
A wound healing powder, comprising a sugar selected from the group consisting of one or more pharmaceutically acceptable monosaccharides and disaccharides, in an amount of at least 25% by weight...